KR100187738B1 - 토포이소메라제 억제제 또는 세포 분화 유도제로서의 5환형 트리테르페노이드 화합물 - Google Patents

토포이소메라제 억제제 또는 세포 분화 유도제로서의 5환형 트리테르페노이드 화합물 Download PDF

Info

Publication number
KR100187738B1
KR100187738B1 KR1019900700818A KR900700818A KR100187738B1 KR 100187738 B1 KR100187738 B1 KR 100187738B1 KR 1019900700818 A KR1019900700818 A KR 1019900700818A KR 900700818 A KR900700818 A KR 900700818A KR 100187738 B1 KR100187738 B1 KR 100187738B1
Authority
KR
South Korea
Prior art keywords
alkyl
mono
cancer
alkenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900700818A
Other languages
English (en)
Korean (ko)
Other versions
KR900701280A (ko
Inventor
유에-웨이 리
키-쳉 팡
첸-구오 왕
데-후아 리
씨. 에드가 쿡
Original Assignee
데이비드 에이치. 파세트
라써치 트라이앵글 인스티튜트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이비드 에이치. 파세트, 라써치 트라이앵글 인스티튜트 filed Critical 데이비드 에이치. 파세트
Publication of KR900701280A publication Critical patent/KR900701280A/ko
Application granted granted Critical
Publication of KR100187738B1 publication Critical patent/KR100187738B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/02—Saturated compounds containing hydroxy or O-metal groups
    • C07C62/06—Saturated compounds containing hydroxy or O-metal groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019900700818A 1988-08-24 1989-08-24 토포이소메라제 억제제 또는 세포 분화 유도제로서의 5환형 트리테르페노이드 화합물 Expired - Fee Related KR100187738B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23590388A 1988-08-24 1988-08-24
US235,903 1988-08-24
PCT/US1989/003581 WO1990001937A1 (en) 1988-08-24 1989-08-24 Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers

Publications (2)

Publication Number Publication Date
KR900701280A KR900701280A (ko) 1990-12-01
KR100187738B1 true KR100187738B1 (ko) 1999-06-01

Family

ID=22887334

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900700818A Expired - Fee Related KR100187738B1 (ko) 1988-08-24 1989-08-24 토포이소메라제 억제제 또는 세포 분화 유도제로서의 5환형 트리테르페노이드 화합물

Country Status (10)

Country Link
EP (1) EP0431076B1 (enExample)
JP (1) JP2828295B2 (enExample)
KR (1) KR100187738B1 (enExample)
CN (1) CN1041204C (enExample)
AU (1) AU630374B2 (enExample)
CA (1) CA1330944C (enExample)
DE (1) DE68909947T2 (enExample)
DK (1) DK31391D0 (enExample)
TW (1) TW225990B (enExample)
WO (1) WO1990001937A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
DE4445728A1 (de) * 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
DE19531067A1 (de) † 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
CA2372772A1 (en) * 1999-04-30 2000-11-09 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
WO2002085921A2 (de) * 2001-03-01 2002-10-31 Johann Jauch Einfaches verfahren zur synthese von boswelliasäuren und derivaten davon
CN1304007C (zh) * 2002-02-04 2007-03-14 中国医学科学院药物研究所 乙酰乳香酸在制备肿瘤转移抑制剂中的应用
US8028292B2 (en) 2004-02-20 2011-09-27 Sony Computer Entertainment Inc. Processor task migration over a network in a multi-processor system
CA2687559A1 (en) * 2007-06-25 2009-04-02 Plant Bioscience Limited Enzymes involved in triterpene synthesis
DE102008015607A1 (de) * 2008-03-26 2009-10-15 Universität Tübingen Verwendung von Boswelliasäuren und synthetischen Boswelliasäurederivaten zur Hemmung der mikrosomalen Prostaglandin E2 Synthase und des Cathepsin G
WO2010105821A1 (de) 2009-03-17 2010-09-23 Herta Ertelt Verfahren zur extraktion von pflanzlichen harzen sowie dadurch gewonnene extraktionsprodukte und deren verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501734A (en) * 1981-03-06 1985-02-26 Wakunaga Yakuhin Kabushiki Kaisha Promotion of absorption of drugs administered through the alimentary system

Also Published As

Publication number Publication date
TW225990B (enExample) 1994-07-01
JPH04500209A (ja) 1992-01-16
EP0431076A4 (en) 1992-01-15
CN1041204C (zh) 1998-12-16
WO1990001937A1 (en) 1990-03-08
KR900701280A (ko) 1990-12-01
DE68909947T2 (de) 1994-02-24
EP0431076B1 (en) 1993-10-13
JP2828295B2 (ja) 1998-11-25
CA1330944C (en) 1994-07-26
EP0431076A1 (en) 1991-06-12
DE68909947D1 (de) 1993-11-18
CN1043131A (zh) 1990-06-20
DK31391A (da) 1991-02-22
AU4303389A (en) 1990-03-23
DK31391D0 (da) 1991-02-22
AU630374B2 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
US5064823A (en) Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
AU2002245022B2 (en) Inhibition of NF-kappaB by triterpene compositions
AU644363B2 (en) New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
KR100187738B1 (ko) 토포이소메라제 억제제 또는 세포 분화 유도제로서의 5환형 트리테르페노이드 화합물
US8075923B2 (en) Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
JP3430322B2 (ja) スポンギスタチン５、７、８及び９
KR19990044409A (ko) 가수분해를 촉진시키는 소수성 탁산 유도체
CZ305745B6 (cs) Fosfolipidové deriváty kyseliny valproové a jejich směsi
JP2921990B2 (ja) コルヒチン誘導体及びその治療的利用
JP6896630B2 (ja) 牛樟芝化合物、その製造方法及び用途
US10214558B2 (en) Natural and synthetic compounds for treating cancer and other diseases
CN104622865B (zh) 巨大戟二萜类化合物在制备抗肿瘤药物中的应用
Christensen et al. From plant to patient: thapsigargin, a tool for understanding natural product chemistry, total syntheses, biosynthesis, taxonomy, ATPases, cell death, and drug development
KR100306430B1 (ko) 콜히친골격화합물과그들의의약품으로서의용도및이들을함유한조성물
JPH09511761A (ja) 抗癌−、抗ウィルス−および植物生長抑制作用をもつ治療用カシノイド製剤
JP2009522239A (ja) トリテルペンキノンおよびトリテルペンフェノール誘導体、ならびに腫瘍および寄生生物性疾患の治療のためのそれらの適用
CN1651395B (zh) 冰片脂肪酸酯衍生物及含有该衍生物的制剂
KR100466522B1 (ko) 항암활성을 갖는 ｊ 300 동충하초 추출물 및 이를함유하는 약제학적 조성물
US20170267714A1 (en) Natural and synthetic compounds for treating cancer and other diseases
JP5246615B2 (ja) 抗腫瘍剤
US5082865A (en) Avarol and its production and use as an antitumor agent (I)
Mohammad et al. Synthesis, characterization, anti-tumor and anti-microbial activity of fatty acid analog of 2, 6-diisopropylphenol
KR20230052446A (ko) 남극 진균 균주 Pleosporales sp. SF-7343 유래 대사화합물을 포함하는 염증질환 예방 또는 치료용 조성물
ES2908500A1 (es) Derivados de andrografolido para su uso en el tratamiento de enfermedades inflamatorias asociadas a una tormenta de citoquinas
JPS63227526A (ja) 親脂性アントラサイクリンを含有する薬剤およびその製法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

FPAY Annual fee payment

Payment date: 20031231

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20050108

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20050108

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000